Keywords: alnylam, isis, form, regulus, thera, jv, rnai

Alnylam and Isis form Regulus Thera JV

Article | 17 September 2007

RNAi therapeutics specialist Alnylam Pharmaceuticals and fellow USA-based firm Isis Pharmaceuticals have announced the launch of a new joint venture, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in